Search
Search Results
##search.searchResults.foundPlural##
-
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1626Suppl. Files: 816HTML: 400PDF: 700 -
-
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2720PDF: 1075HTML: 11203 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1846PDF: 762HTML: 204 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2130PDF: 913HTML: 6766Figure 1: 153 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3632PDF: 1487HTML: 7997Randi Fig: 156 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1318PDF: 782HTML: 3100 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6150PDF: 2025HTML: 13963Untitled: 183figure: 159 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
914PDF: 509HTML: 7793 -
-
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1214PDF: 764HTML: 110 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3116PDF: 963HTML: 1986 -
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
1638PDF: 797Html: 267 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5036PDF: 1284HTML: 2721Cover letter: 173 -
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3155PDF: 1905HTML: 7450 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1137PDF: 683HTML: 1200 -
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1956PDF: 1567HTML: 344 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3018PDF: 1107HTML: 361 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3082PDF: 1096HTML: 1450Untitled: 157Untitled: 147Untitled: 147 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2240PDF: 933HTML: 7603Untitled: 253Fig2: 161Fig3: 141Fig4: 159 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1662PDF: 914HTML: 126 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2503PDF: 824HTML: 17436Fig1 Caligaris: 142Fig.2 Caliga: 175 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1291PDF: 850HTML: 1748 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4300PDF: 1859HTML: 17705 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3621PDF: 1042HTML: 2254Figure 1: 192 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3416PDF: 2323HTML: 1401 -
MIR-140 TARGETS LNCRNA DNAJC3-AS1 TO SUPPRESS CELL PROLIFERATION IN ACUTE MYELOID LEUKEMIA AML proliferation and MIR-140 LNCRNA DNAJC3-AS1 target.
1102PDF: 555HTML: 201 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1818PDF: 813HTML: 1213 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
1941PDF: 879HTML: 122Suppl. Files: 488 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
942PDF: 1067Suppl. Files: 548HTML: 71 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2783PDF: 1300HTML: 3549Untitled: 169Untitled: 180Untitled: 157 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2423PDF: 804HTML: 8784Efremov 1: 204Efremov 2: 161 -
IMMUNOLOGY OF TUBERCULOSIS
5091PDF: 1951HTML: 7244Untitled: 184 -
-
-
-
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3289PDF: 1239HTML: 2187Fi.1 Gritti.Rambaldi: 181 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3224PDF: 1204HTML: 2170 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1189PDF: 449HTML: 18539Figure 1: 151Figure 2: 132Figure 3: 152Figure 4: 185Figure 5: 153







